-
Je něco špatně v tomto záznamu ?
2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects
LG. Rider, N. Ruperto, A. Pistorio, B. Erman, N. Bayat, PA. Lachenbruch, H. Rockette, BM. Feldman, AM. Huber, P. Hansen, CV. Oddis, IE. Lundberg, AA. Amato, H. Chinoy, RG. Cooper, L. Chung, K. Danko, D. Fiorentino, I. García-De la Torre, AM....
Jazyk angličtina Země Velká Británie
Typ dokumentu konsensus - konference, časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 1996 do Před 1 rokem
Open Access Digital Library
od 1996-01-01
Medline Complete (EBSCOhost)
od 1999-01-01 do Před 1 rokem
- MeSH
- dermatomyozitida terapie MeSH
- lidé MeSH
- logistické modely MeSH
- minimální klinicky významný rozdíl MeSH
- plocha pod křivkou MeSH
- polymyozitida terapie MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- konsensus - konference MeSH
- práce podpořená grantem MeSH
Objective: The objective was to describe the methodology used to develop new response criteria for adult DM/PM and JDM. Methods: Patient profiles from prospective natural history data and clinical trials were rated by myositis specialists to develop consensus gold-standard ratings of minimal, moderate and major improvement. Experts completed a survey regarding clinically meaningful improvement in the core set measures (CSM) and a conjoint-analysis survey (using 1000Minds software) to derive relative weights of CSM and candidate definitions. Six types of candidate definitions for response criteria were derived using survey results, logistic regression, conjoint analysis, application of conjoint-analysis weights to CSM and published definitions. Sensitivity, specificity and area under the curve were defined for candidate criteria using consensus patient profile data, and selected definitions were validated using clinical trial data. Results: Myositis specialists defined the degree of clinically meaningful improvement in CSM for minimal, moderate and major improvement. The conjoint-analysis survey established the relative weights of CSM, with muscle strength and Physician Global Activity as most important. Many candidate definitions showed excellent sensitivity, specificity and area under the curve in the consensus profiles. Trial validation showed that a number of candidate criteria differentiated between treatment groups. Top candidate criteria definitions were presented at the consensus conference. Conclusion: Consensus methodology, with definitions tested on patient profiles and validated using clinical trials, led to 18 definitions for adult PM/DM and 14 for JDM as excellent candidates for consideration in the final consensus on new response criteria for myositis.
3rd Department of Internal Medicine Division of Immunology University of Debrecen Debrecen Hungary
Department of Biostatistics University of Pittsburgh Pittsburgh PA USA
Department of Dermatology Stanford University Redwood City CA USA
Department of Economics University of Otago Dunedin New Zealand
Department of Neurology Brigham and Women's Hospital and Harvard Medical School Boston MA USA
Department of Paediatric Rheumatology Great Ormond Street Hospital for Children NHS Trust London UK
Department of Pediatrics Duke University Durham NC USA
Division of Rheumatology Hospital for Sick Children Toronto Ontario
Division of Rheumatology Stanford University Redwood City CA USA
Environmental Autoimmunity Group NIEHS National Institutes of Health Bethesda MD USA
Hospital General de Occidente de la Secretaría de Salud Guadalajara Jalisco Mexico
Institute of Ageing and Chronic Disease University of Liverpool Liverpool UK
Institute of Rheumatology and Department of Rheumatology Charles University Prague Czech Republic
Istituto Giannina Gaslini Pediatria 2 Reumatologia PRINTO
Istituto Giannina Gaslini Servizio di Epidemiologia e Biostatistica Genoa Italy
Pediatric Rheumatology Azienda Ospedaliero Universitaria Meyer University of Florence Florence Italy
Rheumatology Department Izaak Walton Killam Health Centre Halifax Nova Scotia Canada
Rheumatology Unit Karolinska University Hospital Karolinska Institute Stockholm Sweden
Social and Scientific Systems Inc Durham NC
Wilhelmina Children's Hospital University Medical Center Utrecht The Netherlands
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18016302
- 003
- CZ-PrNML
- 005
- 20180517091443.0
- 007
- ta
- 008
- 180515s2017 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1093/rheumatology/kex226 $2 doi
- 035 __
- $a (PubMed)28977549
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Rider, Lisa G $u Environmental Autoimmunity Group, NIEHS, National Institutes of Health, Bethesda, MD, USA.
- 245 10
- $a 2016 ACR-EULAR adult dermatomyositis and polymyositis and juvenile dermatomyositis response criteria-methodological aspects / $c LG. Rider, N. Ruperto, A. Pistorio, B. Erman, N. Bayat, PA. Lachenbruch, H. Rockette, BM. Feldman, AM. Huber, P. Hansen, CV. Oddis, IE. Lundberg, AA. Amato, H. Chinoy, RG. Cooper, L. Chung, K. Danko, D. Fiorentino, I. García-De la Torre, AM. Reed, Y. Wook Song, R. Cimaz, RJ. Cuttica, CA. Pilkington, A. Martini, J. van der Net, S. Maillard, FW. Miller, J. Vencovsky, R. Aggarwal, . ,
- 520 9_
- $a Objective: The objective was to describe the methodology used to develop new response criteria for adult DM/PM and JDM. Methods: Patient profiles from prospective natural history data and clinical trials were rated by myositis specialists to develop consensus gold-standard ratings of minimal, moderate and major improvement. Experts completed a survey regarding clinically meaningful improvement in the core set measures (CSM) and a conjoint-analysis survey (using 1000Minds software) to derive relative weights of CSM and candidate definitions. Six types of candidate definitions for response criteria were derived using survey results, logistic regression, conjoint analysis, application of conjoint-analysis weights to CSM and published definitions. Sensitivity, specificity and area under the curve were defined for candidate criteria using consensus patient profile data, and selected definitions were validated using clinical trial data. Results: Myositis specialists defined the degree of clinically meaningful improvement in CSM for minimal, moderate and major improvement. The conjoint-analysis survey established the relative weights of CSM, with muscle strength and Physician Global Activity as most important. Many candidate definitions showed excellent sensitivity, specificity and area under the curve in the consensus profiles. Trial validation showed that a number of candidate criteria differentiated between treatment groups. Top candidate criteria definitions were presented at the consensus conference. Conclusion: Consensus methodology, with definitions tested on patient profiles and validated using clinical trials, led to 18 definitions for adult PM/DM and 14 for JDM as excellent candidates for consideration in the final consensus on new response criteria for myositis.
- 650 _2
- $a plocha pod křivkou $7 D019540
- 650 _2
- $a dermatomyozitida $x terapie $7 D003882
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a logistické modely $7 D016015
- 650 _2
- $a minimální klinicky významný rozdíl $7 D000071081
- 650 _2
- $a polymyozitida $x terapie $7 D017285
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a konsensus - konference $7 D016446
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Ruperto, Nicolino $u Istituto Giannina Gaslini, Pediatria II - Reumatologia, PRINTO.
- 700 1_
- $a Pistorio, Angela $u Istituto Giannina Gaslini, Servizio di Epidemiologia e Biostatistica, Genoa, Italy.
- 700 1_
- $a Erman, Brian $u Social and Scientific Systems, Inc., Durham, NC.
- 700 1_
- $a Bayat, Nastaran $u Environmental Autoimmunity Group, NIEHS, National Institutes of Health, Bethesda, MD, USA.
- 700 1_
- $a Lachenbruch, Peter A $u Environmental Autoimmunity Group, NIEHS, National Institutes of Health, Bethesda, MD, USA.
- 700 1_
- $a Rockette, Howard $u Department of Biostatistics, University of Pittsburgh, Pittsburgh, PA, USA.
- 700 1_
- $a Feldman, Brian M $u Division of Rheumatology, Hospital for Sick Children, Toronto, Ontario.
- 700 1_
- $a Huber, Adam M $u Rheumatology Department, Izaak Walton Killam Health Centre, Halifax, Nova Scotia, Canada.
- 700 1_
- $a Hansen, Paul $u Department of Economics, University of Otago, Dunedin, New Zealand.
- 700 1_
- $a Oddis, Chester V $u Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
- 700 1_
- $a Lundberg, Ingrid E $u Rheumatology Unit, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden.
- 700 1_
- $a Amato, Anthony A $u Department of Neurology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
- 700 1_
- $a Chinoy, Hector $u National Institute of Health Research Manchester Musculoskeletal Biomedical Research Unit, Central Manchester University Hospitals NHS Foundation Trust. Manchester Academic Health Science Centre, The University of Manchester, Manchester.
- 700 1_
- $a Cooper, Robert G $u Institute of Ageing and Chronic Disease, University of Liverpool, Liverpool, UK.
- 700 1_
- $a Chung, Lorinda $u Division of Rheumatology, Stanford University, Redwood City, CA, USA.
- 700 1_
- $a Danko, Katalin $u 3rd Department of Internal Medicine, Division of Immunology, University of Debrecen, Debrecen, Hungary.
- 700 1_
- $a Fiorentino, David $u Department of Dermatology, Stanford University, Redwood City, CA, USA.
- 700 1_
- $a García-De la Torre, Ignacio $u Hospital General de Occidente de la Secretaría de Salud, Guadalajara, Jalisco, Mexico.
- 700 1_
- $a Reed, Ann M $u Department of Pediatrics, Duke University, Durham, NC, USA.
- 700 1_
- $a Wook Song, Yeong $u Department of Molecular Medicine and Biopharmaceutical Sciences, Medical Research Center, Seoul National University, Seoul, Korea.
- 700 1_
- $a Cimaz, Rolando $u Pediatric Rheumatology, Azienda Ospedaliero Universitaria Meyer, University of Florence, Florence, Italy.
- 700 1_
- $a Cuttica, Rubén J $u Department of Pediatric Rheumatology, Hospital de Niños Pedro de Elizalde, University of Buenos Aires, Buenos Aires, Argentina.
- 700 1_
- $a Pilkington, Clarissa A $u Department of Paediatric Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
- 700 1_
- $a Martini, Alberto $u Istituto Giannina Gaslini, Pediatria II - Reumatologia, PRINTO. Università degli Studi di Genova, Dipartimento di Pediatria, Genoa, Italy.
- 700 1_
- $a van der Net, Janjaap $u Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands.
- 700 1_
- $a Maillard, Susan $u Department of Paediatric Rheumatology, Great Ormond Street Hospital for Children NHS Trust, London, UK.
- 700 1_
- $a Miller, Frederick W $u Environmental Autoimmunity Group, NIEHS, National Institutes of Health, Bethesda, MD, USA.
- 700 1_
- $a Vencovsky, Jiri $u Institute of Rheumatology and Department of Rheumatology, Charles University, Prague, Czech Republic.
- 700 1_
- $a Aggarwal, Rohit $u Department of Medicine, Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
- 700 1_
- $a ,
- 773 0_
- $w MED00011379 $t Rheumatology (Oxford, England) $x 1462-0332 $g Roč. 56, č. 11 (2017), s. 1884-1893
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/28977549 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180517091619 $b ABA008
- 999 __
- $a ok $b bmc $g 1299926 $s 1013142
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2017 $b 56 $c 11 $d 1884-1893 $i 1462-0332 $m Rheumatology $n Rheumatology (Oxford) $x MED00011379
- LZP __
- $a Pubmed-20180515
